Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.88p
   
  • Change Today:
    -0.100p
  • 52 Week High: 20.04
  • 52 Week Low: 5.59
  • Currency: UK Pounds
  • Shares Issued: 585.67m
  • Volume: 3,178,686
  • Market Cap: 34.41m

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart (29-03-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1313.5% -242.8%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 22.7 4.4
Pr/Book 0.8  
Latest F'cast
Revenue -85.4% 422.5%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

STX Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 0.64 (20.99) (16.05)p n/a n/a n/a n/a 0.0%
31-Dec-18 11.88 (5.15) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.57) (8.74)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 7.94 (19.27) (8.32)p n/a n/a n/a n/a 0.0%
31-Dec-23 26.60 (23.37) (4.59)p n/a n/a n/a n/a 0.0%
31-Dec-24 84.01 6.33 0.03p 176.3 n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

STX Company Announcements

Price Monitoring Extension 15-Mar-2023 16:35 RNS
Total Voting Rights Update 28-Feb-2023 07:00 RNS
Second Price Monitoring Extn 17-Feb-2023 11:05 RNS

Latest STX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

STX Market Data

Currency UK Pounds
Share Price 5.88p
Change Today -0.100p
% Change -1.67 %
52 Week High 20.04
52 Week Low 5.59
Volume 3,178,686
Shares Issued 585.67m
Market Cap 34.41m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.76% above the market average15.76% above the market average15.76% above the market average15.76% above the market average15.76% above the market average
69.49% above the sector average69.49% above the sector average69.49% above the sector average69.49% above the sector average69.49% above the sector average
Price Trend
90.93% below the market average90.93% below the market average90.93% below the market average90.93% below the market average90.93% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth
20.05% above the market average20.05% above the market average20.05% above the market average20.05% above the market average20.05% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 29-Mar-2023

Time Volume / Share Price
16:45 680,471 @ 5.90p
16:41 300,000 @ 5.90p
16:35 19 @ 5.80p
16:35 125 @ 5.95p
16:27 384,077 @ 5.90p

Top of Page